Editas Medicine (NASDAQ:EDIT) Shares Gap Up on Analyst Upgr

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) gapped up before the market opened on Wednesday after Truist Financial raised their price target on the stock from $15.00 to $20.00. The stock had previously closed at $9.84, but opened at $10.38. Truist Financial currently has a buy rating on the stock. Editas Medicine shares last […]

Related Keywords

Stifel Nicolaus , Jpmorgan Chase Co , Citigroup , Nasdaq , Cantor Fitzgerald , Editas Medicine Company Profile , Blackrock Inc , Marshall Wace , Editas Medicine Inc , Vanguard Group Inc , Editas Medicine , Get Free Report , Truist Financial , Street Corp , Track Capital , Leber Congenital Amaurosis , Editas Medicine Daily , Nasdaq Edit , Credit , Medical , Stocks , Technicals ,